Author
Harvard UniversityORCID 0000-0002-1214-4103Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Daniela Bossi, Arianna Vallerga, Giuseppe Salfi…·Jean-Philippe Paul. Theurillat
This study identifies TRIM24 as a target for preventing prostate cancer progression by degrading it to counteract AR inhibition adaptation and tumor relapse.
April Ann Apfelbaum, Eric Morin, Dominik Sturm…·Pratiti Bandopadhayay
This study identifies FGFR alterations in pediatric gliomas, their association with specific histologies, and their response to targeted therapies.
Nienke Moret, Nicholas A. Clark, Marc A. Hafner…·Peter Karl Sorger
The paper develops tools to compare and design optimized small molecule libraries using chemical and biological data, resulting in a more effective kinase inhibitor library.